Cardiol on why the Phase III MAVERIC trial is expanding
Video by International Investment Forum (IIF) · Oct 10
TSX: CRDL · Biotechnology, cardiovascular Sponsored
Cardiol Therapeutics Inc. is a clinical-stage life sciences company developing anti-inflammatory and anti-fibrotic therapies for heart disease. Its lead product candidate is CardiolRx, an oral cannabidiol formulation.
Cardiol Therapeutics Inc. is a clinical-stage life sciences company developing anti-inflammatory and anti-fibrotic therapies for heart disease. Its lead product candidate is CardiolRx, an oral cannabidiol formulation.
From Cardiol Therapeutics Inc's own disclosure. Read its filings on SEDAR+ for the full picture.
Interviews, company presentations and operational updates.
Video by International Investment Forum (IIF) · Oct 10
Video by The Deep Dive · Oct 8
Latest corporate announcements, linked to the original source.
Receive company announcements, investor materials and selected updates directly by email.
Content is for information only and is not investment advice or a recommendation to buy, sell or hold any security. Read the full disclosures.